A new case report was published in Volume 13 of Oncoscience on March 11, 2026, titled “Deceptive clinical course of mucinous ...

Anything related to anal health is often ignored, misunderstood, or awkward to talk about. Most people tend to label every discomfort in that area as "piles", but that's not always the case.

For all its success across a wide range of cancer types, Merck’s PD-1 superstar Keytruda has never been able to crack the code for one of the toughest-to-treat indications in oncology—ovarian cancer.

FDA approves pembrolizumab with chemotherapy for platinum-resistant ovarian cancer, showing significant survival benefits in clinical trials. The FDA has approved pembrolizumab (Keytruda) plus ...

No matter where you are in the ovarian cancer treatment journey, waiting — whether for test results or the next steps — can be stressful. Throughout the treatment process, anywhere from one-third to ...

Ovarian mucinous cystadenocarcinoma is a rare malignant epithelial tumor, accounting for approximately 10–15% of ovarian carcinomas. It typically presents with nonspecific abdominal symptoms and may ...

Adding opportunistic bilateral salpingectomy (OBS) to hysterectomies reduced serous ovarian cancer risk by nearly 80%. An analysis of ovarian cancers after OBS showed that 23% were high-grade serous ...

About The Study: Existing evidence demonstrates that opportunistic salpingectomy (removal of the fallopian tubes during unrelated pelvic or abdominal surgery) is significantly associated with a lower ...

ABSTRACT: Background: Complicated Upper Genital Tract Infections (CUGTI), such as tubo-ovarian abscesses and pelvic peritonitis, represent severe gynecological emergencies with significant ...

ABSTRACT: Background: Complicated Upper Genital Tract Infections (CUGTI), such as tubo-ovarian abscesses and pelvic peritonitis, represent severe gynecological emergencies with significant ...

CLEVELAND, Ohio — As many as 8,000 women in the United States are living with a rare ovarian cancer that affects the young and keeps coming back, even after surgery and chemotherapy. Now, for the ...

Rising ovarian and uterine cancer rates are linked to high BMI, with disparities across sociodemographic index levels, particularly in low- and middle-SDI regions. Sarcopenia is prevalent in ...